GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BSE:BAYN) » Definitions » Cyclically Adjusted PB Ratio

Bayer AG (BSE:BAYN) Cyclically Adjusted PB Ratio : 0.65 (As of Jun. 01, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Bayer AG Cyclically Adjusted PB Ratio?

As of today (2024-06-01), Bayer AG's current share price is lei140.30. Bayer AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was lei216.18. Bayer AG's Cyclically Adjusted PB Ratio for today is 0.65.

The historical rank and industry rank for Bayer AG's Cyclically Adjusted PB Ratio or its related term are showing as below:

BSE:BAYN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.61   Med: 2.29   Max: 6.28
Current: 0.66

During the past years, Bayer AG's highest Cyclically Adjusted PB Ratio was 6.28. The lowest was 0.61. And the median was 2.29.

BSE:BAYN's Cyclically Adjusted PB Ratio is ranked better than
82.48% of 725 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs BSE:BAYN: 0.66

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bayer AG's adjusted book value per share data for the three months ended in Mar. 2024 was lei180.832. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is lei216.18 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bayer AG Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted PB Ratio Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.21 1.42 1.30 1.20 0.79

Bayer AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 1.20 1.07 0.79 0.66

Competitive Comparison of Bayer AG's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted PB Ratio falls into.



Bayer AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bayer AG's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=140.30/216.18
=0.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bayer AG's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=180.832/125.0381*125.0381
=180.832

Current CPI (Mar. 2024) = 125.0381.

Bayer AG Quarterly Data

Book Value per Share CPI Adj_Book
201406 144.354 99.543 181.327
201409 142.108 99.823 178.005
201412 135.430 99.543 170.117
201503 128.498 99.717 161.128
201506 136.703 100.417 170.222
201509 137.837 100.417 171.634
201512 144.393 99.717 181.059
201603 143.710 100.017 179.662
201606 139.447 100.717 173.121
201609 143.429 101.017 177.536
201612 174.790 101.217 215.926
201703 196.407 101.417 242.153
201706 200.402 102.117 245.384
201709 246.097 102.717 299.575
201712 237.910 102.617 289.891
201803 248.841 102.917 302.327
201806 271.112 104.017 325.901
201809 288.596 104.718 344.599
201812 257.001 104.217 308.345
201903 266.478 104.217 319.715
201906 236.403 105.718 279.607
201909 236.534 106.018 278.970
201912 245.323 105.818 289.883
202003 250.969 105.718 296.835
202006 187.869 106.618 220.327
202009 172.410 105.818 203.726
202012 173.503 105.518 205.601
202103 192.397 107.518 223.748
202106 171.076 108.486 197.178
202109 170.976 109.435 195.354
202112 174.335 110.384 197.480
202203 192.649 113.968 211.361
202206 187.785 115.760 202.835
202209 190.935 118.818 200.931
202212 191.915 119.345 201.070
202303 204.431 122.402 208.833
202306 187.043 123.140 189.925
202309 166.456 124.195 167.587
202312 167.778 123.773 169.493
202403 180.832 125.038 180.832

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bayer AG  (BSE:BAYN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bayer AG Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (BSE:BAYN) Business Description

Industry
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (BSE:BAYN) Headlines